Candida auris, a drug-resistant fungus, is a concern in healthcare settings, with efforts focused on preventing its spread and controlling outbreaks. Reports indicate that infections persist, and various guidance and reviews have been published on its global epidemiology, multidrug resistance, and infection control. Prevention and response measures are being implemented in different regions, including guidance specific to certain areas such as pediatric settings and healthcare facilities.